vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Inspirato Inc (ISPO). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $55.5M, roughly 1.1× Inspirato Inc). Inspirato Inc runs the higher net margin — -8.1% vs -70.9%, a 62.8% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs -19.6%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-3.0M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -11.4%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Inspirato Inc is a luxury travel and hospitality subscription service provider catering primarily to high-net-worth consumers across North America. It offers curated premium villa rentals, exclusive resort access, customized trip planning, and corporate travel incentive solutions for enterprise clients.
CTKB vs ISPO — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $55.5M |
| Net Profit | $-44.1M | $-4.5M |
| Gross Margin | 52.9% | 31.4% |
| Operating Margin | -9.0% | -8.0% |
| Net Margin | -70.9% | -8.1% |
| Revenue YoY | 8.1% | -19.6% |
| Net Profit YoY | -557.1% | -204.4% |
| EPS (diluted) | — | $-0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | — | ||
| Q3 25 | $52.3M | $55.5M | ||
| Q2 25 | $45.6M | $63.1M | ||
| Q1 25 | $41.5M | $65.9M | ||
| Q4 24 | $57.5M | $63.1M | ||
| Q3 24 | $51.5M | $69.1M | ||
| Q2 24 | $46.6M | $67.4M | ||
| Q1 24 | $44.9M | $80.2M |
| Q4 25 | $-44.1M | — | ||
| Q3 25 | $-5.5M | $-4.5M | ||
| Q2 25 | $-5.6M | $-5.3M | ||
| Q1 25 | $-11.4M | $1.6M | ||
| Q4 24 | $9.6M | $-2.3M | ||
| Q3 24 | $941.0K | $4.3M | ||
| Q2 24 | $-10.4M | $-8.7M | ||
| Q1 24 | $-6.2M | $1.3M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | 31.4% | ||
| Q2 25 | 52.3% | 27.5% | ||
| Q1 25 | 48.6% | 38.8% | ||
| Q4 24 | 58.5% | 34.7% | ||
| Q3 24 | 56.3% | 71.5% | ||
| Q2 24 | 54.6% | 24.0% | ||
| Q1 24 | 51.3% | 39.5% |
| Q4 25 | -9.0% | — | ||
| Q3 25 | -17.6% | -8.0% | ||
| Q2 25 | -23.3% | -8.3% | ||
| Q1 25 | -36.1% | 2.5% | ||
| Q4 24 | 5.2% | -3.2% | ||
| Q3 24 | -8.2% | 9.8% | ||
| Q2 24 | -18.3% | -22.8% | ||
| Q1 24 | -23.9% | 3.0% |
| Q4 25 | -70.9% | — | ||
| Q3 25 | -10.5% | -8.1% | ||
| Q2 25 | -12.2% | -8.4% | ||
| Q1 25 | -27.5% | 2.5% | ||
| Q4 24 | 16.8% | -3.6% | ||
| Q3 24 | 1.8% | 6.3% | ||
| Q2 24 | -22.4% | -12.9% | ||
| Q1 24 | -13.8% | 1.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.36 | ||
| Q2 25 | — | $-0.42 | ||
| Q1 25 | — | $0.12 | ||
| Q4 24 | — | $0.98 | ||
| Q3 24 | — | $0.62 | ||
| Q2 24 | — | $-2.33 | ||
| Q1 24 | — | $-0.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $13.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $-134.0M |
| Total Assets | $461.5M | $228.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | — | ||
| Q3 25 | $93.3M | $13.7M | ||
| Q2 25 | $75.5M | $16.7M | ||
| Q1 25 | $95.3M | $16.4M | ||
| Q4 24 | $98.7M | $21.8M | ||
| Q3 24 | $162.3M | $13.5M | ||
| Q2 24 | $177.9M | $18.8M | ||
| Q1 24 | $168.8M | $22.6M |
| Q4 25 | $341.7M | — | ||
| Q3 25 | $378.6M | $-134.0M | ||
| Q2 25 | $377.6M | $-129.7M | ||
| Q1 25 | $379.6M | $-125.2M | ||
| Q4 24 | $395.7M | $-129.9M | ||
| Q3 24 | $385.5M | $-134.6M | ||
| Q2 24 | $389.1M | $-35.2M | ||
| Q1 24 | $392.6M | $-27.5M |
| Q4 25 | $461.5M | — | ||
| Q3 25 | $494.9M | $228.3M | ||
| Q2 25 | $493.3M | $252.6M | ||
| Q1 25 | $482.6M | $270.1M | ||
| Q4 24 | $499.5M | $273.9M | ||
| Q3 24 | $491.2M | $273.3M | ||
| Q2 24 | $483.7M | $301.7M | ||
| Q1 24 | $492.1M | $313.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $-2.2M |
| Free Cash FlowOCF − Capex | $-1.8M | $-3.0M |
| FCF MarginFCF / Revenue | -2.9% | -5.4% |
| Capex IntensityCapex / Revenue | 1.6% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $-31.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | — | ||
| Q3 25 | $-3.9M | $-2.2M | ||
| Q2 25 | $108.0K | $1.1M | ||
| Q1 25 | $-125.0K | $-6.6M | ||
| Q4 24 | $2.0M | $-15.8M | ||
| Q3 24 | $13.2M | $-13.7M | ||
| Q2 24 | $6.2M | $-1.8M | ||
| Q1 24 | $4.0M | $-7.2M |
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-4.6M | $-3.0M | ||
| Q2 25 | $-1.5M | $468.0K | ||
| Q1 25 | $-974.0K | $-7.5M | ||
| Q4 24 | $1.1M | $-21.2M | ||
| Q3 24 | $12.2M | $-14.8M | ||
| Q2 24 | $5.2M | $-3.7M | ||
| Q1 24 | $3.4M | $-8.5M |
| Q4 25 | -2.9% | — | ||
| Q3 25 | -8.7% | -5.4% | ||
| Q2 25 | -3.2% | 0.7% | ||
| Q1 25 | -2.3% | -11.4% | ||
| Q4 24 | 1.9% | -33.7% | ||
| Q3 24 | 23.7% | -21.5% | ||
| Q2 24 | 11.0% | -5.5% | ||
| Q1 24 | 7.6% | -10.6% |
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.3% | 1.4% | ||
| Q2 25 | 3.5% | 1.0% | ||
| Q1 25 | 2.0% | 1.3% | ||
| Q4 24 | 1.6% | 8.7% | ||
| Q3 24 | 2.0% | 1.6% | ||
| Q2 24 | 2.3% | 2.8% | ||
| Q1 24 | 1.3% | 1.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -4.09× | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | -3.16× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -5.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
ISPO
| Residence And Hotel Travel | $25.9M | 47% |
| Subscription | $19.4M | 35% |
| Experiences And Bespoke Travel | $8.0M | 14% |
| Rewards And Other Revenue | $2.3M | 4% |
